Abstract: The invention relates generally to digestive disorders, and in particular to methods for treating irritable bowel syndrome by increasing carbohydrate absorption by administering a composition containing a Bacillus coagulans bacterium.
Abstract: Lactococcus lactis strains with improved preservation characteristics, and improved acid and bile salt tolerance are disclosed. More specifically, a L. lactis strain having a heterologous trehalose-6-phosphate synthase gene and/or a trehalose-6-phosphate phosphatase gene, results in an accumulation of trehalose in the cytoplasm and/or in the cytoplasmic membrane. A L. lactis strain, having an internal trehalose concentration of at least 10 mg per gram cells (w/w) is disclosed.
Abstract: [Problem] To provide an alcoholic fermentation yeast having resistance to limonene, which is a fermentation inhibitor, and a method for producing ethanol using the alcoholic fermentation yeast. [Solution] An alcoholic fermentation yeast Saccharomyces cerevisiae (Deposition No. NITE BP-890), which has resistance to limonene and can grow in the presence of limonene at a concentration of 0.1-0.5 wt %, and a method for producing ethanol using the alcoholic fermentation yeast.
Abstract: The present invention relates to a selected strain of Lactobacillus pentosus for use as a medication for the preventive or curative treatment of infections due to Gram-negative bacteria, preferably enterococci, coliforms and E. coli.
Type:
Grant
Filed:
May 27, 2010
Date of Patent:
November 17, 2015
Assignee:
Probiotical S.p.A.
Inventors:
Giovanni Mogna, Gian Paolo Strozzi, Luca Mogna
Abstract: A yeast including a cell wall having a low mannan content, wherein the yeast has an immunopotentiating capability, and is able to grow in a YPD liquid medium with an osmotic pressure of 300 mOsm, and wherein, when a part of a pre-culture of the yeast grown in a YPDS liquid medium is added to the YPD liquid medium so that OD660 is adjusted to 0.1, followed by incubating at 30° C. for 24 hours, the yeast grows to increase the OD660 of the YPD liquid medium to 1.0 or more.
Abstract: The present invention refers to a process for bacterial stabilizing aqueous preparations like e.g. calcium carbonate slurries and a composition which can be used for the biocidal treatment of such aqueous preparations.
Type:
Grant
Filed:
April 1, 2009
Date of Patent:
August 18, 2015
Assignee:
Omya International AG
Inventors:
Nicola Di Maiuta, Patrick Schwarzentruber, Matthias Buri, Patrick Arthur Charles Gane
Abstract: The present invention provides a natural yeast extract having a high-impact first taste by containing glutamic acid in a large amount. Further, the present invention provides a yeast extract having strong umami by containing 5?-guanylic acid or 5?-inosinic acid in a large amount. In addition, the present invention provides a yeast mutant accumulating glutamic acid, glutamine, and ribonucleic acid in a large amount for obtaining the yeast extract. A yeast mutant inducing a natural mutation to which organic acid-tolerance or organic acid analogue-tolerance is imparted accumulates free glutamic acid and glutamine in such a significant amount as a total amount of 10% by weight or more in a cell, and further accumulates ribonucleic acid in an amount of 5% by weight or more. A yeast extract produced using the above yeast mutant contains L-glutamic acid in an amount of 20% by weight or more, and further contains 5?-IG in an amount of 3% by weight or more.
Abstract: The invention relates to a growth medium allying a fluorogenic substrate and a pH-sensitive fluorophore, in particular the combination of 4-methylumbelliferone (4-MU) and derivatives of fluorescein. This growth medium is used for the detection by fluorescence of microorganisms by coupling the fluorescence measurements relating to the pH-sensitive fluorophor and the fluorescence measurements relating to the activation of the fluorogenic substrate(s) by the microorganisms.
Abstract: This invention is a process for the preparation of talc based formulation for LDPE-degrading bacterial consortia. The process comprises preparing an active consortium. The active consortium is divided into four parts in centrifuge tubes. The tubes are spun at 5000 rpm. A supernatant is decanted from the tubes. The tubes are vortexed. Talc is added to each tube. The tubes with talc are again vortexed for some time to produce a homogeneous mixture. The mixture is poured into glass dishes. The dishes are kept at room temperature as aseptically for drying.
Type:
Grant
Filed:
October 28, 2011
Date of Patent:
June 16, 2015
Assignees:
Department of Biotechnology Delhi, G.B. Pant University of Agriculture and Technology
Abstract: The present invention relates to microorganisms capable of producing isolable amounts of styrene and/or 7-methyl-1,3,5-cyclooctatriene (MCOT) and uses thereof. The present invention also relates to methods for biosynthetically preparing styrene and/or 7-methyl-1,3,5-cyclooctatriene (MCOT) utilizing microorganisms capable of producing isolable amounts of styrene and/or 7-methyl-1,3,5-cyclooctatriene (MCOT).
Type:
Grant
Filed:
November 5, 2008
Date of Patent:
June 16, 2015
Assignee:
The United States of America, as represented by the Secretary of Agriculture
Inventors:
John J. Beck, Glory B. Merrill, Jeffrey D. Palumbo, Teresa L. O'Keeffe
Abstract: The present invention relates to a method of culturing bacterial organisms belonging to the family Anaplasmataceae in mammalian embryonic or fetal cells. In particular, the present invention is directed to growth of bacterial organisms belonging to the family Anaplasmataceae including organisms belonging to the Anaplasma, Ehrlichia and Neorickettsia genera. The bacterial organisms may be cultured in mammalian embryonic or fetal host cells including feline embryonic host cells. Bacterial material cultured according to the methods described herein may be used as the basis for vaccines against diseases associated with the Anaplasmataceae bacteria, or as the basis for diagnostic applications useful for diagnosing diseases associated with the Anaplasmataceae bacteria.
Type:
Grant
Filed:
September 11, 2008
Date of Patent:
June 9, 2015
Assignee:
Intervet International B.V.
Inventors:
Jane Kwun-Lai Battles, Kimberly D. Proudfoot, Brenda L. Meding, Patrick G. Funk, R. Monty Warthen, F. Randall Bethke, Eric A. Ellis, Amy Y. Purse
Abstract: Treatments for chronic enterocolitis are disclosed. More specifically, methods for administration of pharmaceutical compositions that include anti-TNF-alpha antibody producing lactic acid microorganisms, such as Lactobacillus sp. and Saccharomyces sp., are disclosed for the treatment of chronic enterocolitis.
Abstract: It is an objective of the present invention to provide a process for efficiently producing poly-?-glutamic acid having a high L-glutamic acid content and excellent quality. The process for producing poly-?-glutamic acid according to the present invention is characterized in using a bacterium belonging to species Bacillus megaterium.
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
Type:
Grant
Filed:
April 18, 2008
Date of Patent:
December 2, 2014
Assignees:
The Iams Company, Alimentary Health
Inventors:
Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria pseudolongum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria pseudolongum of the present invention are also provided.
Type:
Grant
Filed:
April 18, 2008
Date of Patent:
December 2, 2014
Assignees:
The Iams Company, Alimentary Health, Ltd.
Inventors:
Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
Abstract: A heavy metal-resistant recombinant bacterium capable to remove mercury (II) species, cadmium and copper (II) in presence of other heavy metals from polluted sites, which corresponds to Cupriavidus metallidurans strain MSR33, deposited under the access number NRRL B-50299, a product for the bioremediation of environments contaminated with heavy metals, where the product includes a bacterial inoculum of this recombinant strain, the process of obtaining the product and a method for the bioremediation of environments contaminated with heavy metals, which uses this product for the bioremediation.
Type:
Grant
Filed:
December 20, 2010
Date of Patent:
September 30, 2014
Assignee:
Universidad Tecnica Federico Santa Maria
Inventors:
Michael Seeger Pfeiffer, Luis Antonio Rojas Araya, Myriam Lydia Gonzalez Vergara, Carolina Elvira Maria Ya{circumflex over (n)}ez Prieto
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacteria globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacteria globosum of the present invention are also provided.
Type:
Grant
Filed:
November 3, 2008
Date of Patent:
September 23, 2014
Assignees:
The Iams Company, Alimentary Health, Ltd.
Inventors:
Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers
Abstract: A process for the use of low concentration levels of Penicillin G Procaine to eliminate or control the growth of unwanted or undesirable bacteria (contaminating bacteria) in the fermentation production of alcohol without inhibition of the growth or replication of the yeast.
Type:
Grant
Filed:
December 5, 2008
Date of Patent:
September 9, 2014
Assignee:
Lallemand Specialites, Inc
Inventors:
Kevin E. Dailey, Sanjoy Ganguly, Kevin L. Kauers, Limei Tang, Daniel W. Thon
Abstract: According to the invention there is provided a strain of lactic acid bacteria of the species Bifidobacterium globosum obtainable by isolation from resected and washed canine gastrointestinal tract having a probiotic activity in animals. Methods of use and compositions comprising the Bifidobacterium globosum of the present invention are also provided.
Type:
Grant
Filed:
October 31, 2008
Date of Patent:
August 19, 2014
Assignees:
The Iams Company, Alimentary Health, Ltd.
Inventors:
Thomas William-Maxwell Boileau, Michael Anthony Ceddia, John Kevin Collins, Gary Mitchell Davenport, Barry Pius Kiely, Liam Diarmuid O'Mahony, Gregory Dean Sunvold, Mark Alan Tetrick, Robert Jason Vickers